Beijing, China

Yi Rao

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Gritgen Therapeutics Limited, Peking University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi Rao. Retrieved from https://idiyas.com/inventor/yi-rao-r0yruk5n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yi Rao: Innovator in Biomedicine

Introduction

Yi Rao is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biomedicine, particularly through his innovative research and development efforts. With a total of 2 patents to his name, he has established himself as a key figure in his area of expertise.

Latest Patents

Yi Rao's latest patents include the "Use of Bile Acids and Derivatives Thereof in Preparation of GPR39 Agonist" and "Isolated Nucleic Acid Molecule and Application Thereof." These patents reflect his commitment to advancing medical science and improving therapeutic options.

Career Highlights

Throughout his career, Yi Rao has worked with notable organizations such as Gritgen Therapeutics Limited and Peking University. His work in these institutions has allowed him to collaborate with other experts and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Enxing Zhou and Tenghui Yu. Their collaborative efforts have further enhanced the impact of his research in the scientific community.

Conclusion

Yi Rao's innovative work and patents demonstrate his dedication to advancing biomedicine. His contributions continue to influence the field and inspire future research endeavors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…